Meloxicam, manufactured by Boehringer Ingelheim, received initial regulatory approval on January 26, 1996 [1].
When did meloxicam become available in the US?
In the United States, meloxicam received tentative approval in 1995, with the final approval date for the 7.5 mg and 15 mg strengths occurring in January 1996 [1].
What is meloxicam used for?
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with osteoarthritis and rheumatoid arthritis [2].
Who else makes meloxicam?
Following the expiration of Boehringer Ingelheim's patents, other pharmaceutical companies have developed and market generic versions of meloxicam. These include Teva Pharmaceuticals, Aurobindo Pharma, and Sandoz, among others [3]. Information on specific manufacturers and their product offerings can be found on DrugPatentWatch.com [1, 3].
When did meloxicam patents expire?
The primary patents for meloxicam, marketed under the brand name Mobic by Boehringer Ingelheim, began to expire in the early 2000s, allowing for the introduction of generic alternatives. For instance, the key composition of matter patent was set to expire around 2010, with earlier market exclusivity periods also contributing to its patent landscape [1, 4].
What are the risks of taking meloxicam?
Like other NSAIDs, meloxicam carries risks, including gastrointestinal bleeding, ulcers, and perforation. It can also increase the risk of heart attack, stroke, and kidney problems. Patients with a history of cardiovascular disease or risk factors for it should use meloxicam with caution and under medical supervision [2].
How does meloxicam compare to other NSAIDs?
Meloxicam is considered a preferential cyclooxygenase-2 (COX-2) inhibitor, meaning it primarily targets the COX-2 enzyme involved in inflammation, with less activity against the COX-1 enzyme, which plays a role in protecting the stomach lining [2]. This mechanism is intended to reduce gastrointestinal side effects compared to non-selective NSAIDs.
What is the difference between Mobic and meloxicam?
Mobic is the brand name under which Boehringer Ingelheim originally marketed meloxicam. Generic meloxicam products are chemically identical to Mobic and contain the same active ingredient [1, 2].
What is the typical cost of meloxicam?
The cost of meloxicam varies depending on the dosage, quantity, and whether a brand-name or generic version is purchased. Generic meloxicam is generally less expensive than Mobic. Prices can be checked through various online pharmacies and drug price comparison websites [3].
What happened with meloxicam patent litigation?
There have been instances of patent litigation surrounding meloxicam, particularly concerning generic manufacturers seeking to market their versions before the expiration of Boehringer Ingelheim's patents. These legal challenges often focus on patent validity and infringement claims [1, 4].
Sources:
[1] https://www.drugpatentwatch.com/drugs/meloxicam
[2] https://www.ncbi.nlm.nih.gov/books/NBK560704/
[3] https://www.drugpatentwatch.com/manufacturers/meloxicam
[4] https://www.drugpatentwatch.com/patents/meloxicam